Avalyn Pharma Appoints Executive to Board

Avalyn Pharma Inc. has appointed Jon Congleton, a seasoned biopharmaceutical executive, to its Board of Directors. Congleton brings extensive industry experience to the clinical-stage company. His expertise is expected to provide valuable guidance as Avalyn advances its pipeline of inhaled therapies. This strategic addition to the board signals a focus on strengthening leadership and driving the company's growth and development in the pharmaceutical sector.